dockets: FDA-2003-P-0120

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id	agency_id	title	docket_type	last_modified	object_id
FDA-2003-P-0120	FDA	Request whether Cataflam (diclofenac Potassium) Tablets 25 mg (NDA 20-12) mfged by Novartis Pharmaceuticals Corporation, has been voluntarily withdrawn or withheld from sale for safety or effectiveness reasons.	Nonrulemaking	2021-09-01T01:02:56Z	0b0000648048599d

Links from other tables